Sector Focus


Caliber has successfully planned with both venture backed private development stage companies and publicly traded biopharmaceutical companies. We understand the unique challenges of emerging companies as well as global biotech organizations and we have developed a keen sense of what it takes to discover and develop biologically derived treatments to enhance the quality of care in markets with substantially under met medical needs.


Sonus Pharmaceuticals (now OncoGenex Pharmaceuticals)

Sonus Pharmaceuticals, Inc. was focused on the development of cancer drugs that are designed to provide better efficacy, safety and tolerability, and are more convenient to use. Sonus utilized PEGylation technology platform.

Search Projects

  • Senior Vice President, Clinical Development
  • Head, Clinical Oncology